The University of Queensland

Safety and tolerability of Trimetazidine for the treatment of ALS (2020–2025)

Grant type:

Cure for MND Foundation - Drug Development Grants

Researchers:

• 

  Associate Professor Shyuan Ngo

  Principal Research Fellow
  

  Australian Institute for Bioengineering and Nanotechnology

• 

  Associate Professor Frederik Steyn

  Associate Professor
  

  School of Biomedical Sciences

  Faculty of Medicine

Funded by:

Cure for MND Foundation